Table 1 Comparison of parameters between adverse outcome (+) group and adverse outcome (−) patients in all enrolled patients (mean ± SD)
Adverse outcome (+) group (n = 38) | Adverse outcome (−) group (n = 303) | p value | |
|---|---|---|---|
Age (year) | 61.34 ± 12.72 | 60.60 ± 14.90 | 0.770 |
Sex (male/female) | 18/20 | 136/167 | 0.936 |
RA volume (ml) | 57.68 ± 14.97 | 54.69 ± 15.45 | 0.251 |
LA volume (ml) | 44.46 ± 14.16 | 59.69 ± 13.85 | < 0.001 |
RV volume (ml) | 64.86 ± 21.58 | 51.05 ± 16.57 | < 0.001 |
LV volume (ml) | 51.71 ± 12.25 | 63.57 ± 9.93 | < 0.001 |
RA/LA volume ratio | 1.50 ± 0.82 | 0.97 ± 0.41 | < 0.001 |
RV/LV volume ratio | 1.34 ± 0.66 | 0.82 ± 0.30 | < 0.001 |
CPA embolism/non/CPA embolism | 31/7 | 103/200 | < 0.001 |
Saddle CPA embolism/non-saddle CPA embolism | 9/29 | 10/293 | < 0.001 |